Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 872

Here the notorious but eloquent transhumanism critic Wesley J. Smith takes a swipe at the quickly growing movement to overcome death with science. New story in Merion West!

“Utopians often produce evil because their movement’s aspirations become paramount —that is, more important than avoiding acts ‘traditionally perceived as immoral.’ If enough people follow Istvan on the transhuman roller coaster, people could eventually get hurt.”

“I’m not afraid of dying. I just don’t want to be there when it happens.” – Woody Allen.

In 2016, transhumanism proselytizer Zoltan Istvan ran for president promising to defeat death while touring the country in a bus redesigned to look like a coffin. It was a great gimmick that made him, perhaps, the most famous transhumanist in the world.

Continue reading “Why Transhumanism Is Unrealistic and Immoral” | >

A real stinker.

The trial, conducted by Amazon Web Services, was commissioned by the government regulator as a proof of concept for generative AI’s capabilities, and in particular its potential to be used in business settings.

That potential, the trial found, is not looking promising.

In a series of blind assessments, the generative AI summaries of real government documents scored a dire 47 percent on aggregate based on the trial’s rubric, and were decisively outdone by the human-made summaries, which scored 81 percent.

Continue reading “Government Test Finds That AI Wildly Underperforms Compared to Human Employees” | >

A Space Force officer will command a mission later this month to safely bring home two astronauts who have been unexpectedly stuck aboard the International Space Station, or ISS, marking the first time a Guardian will launch into space for such a high-profile operation.

Col. Nick Hague, an active-duty Space Force Guardian, will be joined by Roscosmos cosmonaut Aleksandr Gorbunov aboard the SpaceX Dragon spacecraft for NASA’s Crew-9 mission. Originally, Hague and Gorbunov were supposed to be joined by two other astronauts for a trip to space, but problems with the Boeing Starliner spacecraft that have left astronauts Barry Wilmore and Sunita Williams stuck aboard the space station for months longer than anticipated shifted the mission objective, date and staffing.

Hague and Gorbunov will launch no earlier than Sept. 24, NASA said in a Friday news release, and will return to Earth with Wilmore and Williams in February 2025. The Guardian and the cosmonaut were chosen for their particular experience and skill sets, the agency said.

Read more | >

Scientists have grown blood stem cells in the laboratory for the first time in a move that could potentially end the need for stem cell transplants.

During a stem cell (or bone marrow) transplant, damaged blood cells are replaced with healthy ones and can be used to treat conditions such as leukaemia.

However, finding a donor match can be difficult and some patients die before a donor is found.

Read more | >

Finally, the goal of any healthcare organization is to provide the best possible care to patients. Predictive AI can contribute significantly to this goal by enabling more accurate diagnoses, tailored treatment plans and earlier interventions.

From the patient’s perspective, this translates to better health outcomes, reduced hospital stays and increased satisfaction with their care. For healthcare organizations, improved patient experiences lead to higher patient retention rates, positive word-of-mouth referrals and better performance on patient satisfaction metrics, which are increasingly tied to reimbursement rates in many healthcare systems.

As we’ve explored, the benefits of predictive AI extend far beyond improved diagnostics and treatment plans. It’s a catalyst for operational excellence, financial optimization, availability of investments and long-term growth. From resource management to building an authoritative brand, predictive AI touches every aspect of the healthcare business environment.

Read more | >

Nowadays, there’s lots of buzz about spectacular new medical treatments, such as personalized cancer therapy with modified immune cells or antibodies. Such treatments, however, are very complex and expensive and so find only limited application. Most medical therapies are still based on small chemical compounds that can be produced in large quantities and thus at low cost.

Read more | >